CBD has some other very important roles outside the ECS. For instance, CBD mildly activates one of the brain’s predominant serotonin receptors (5-HT1A) in mice, which may explain its supposed effects on depression and anxiety . It also acts at the peroxisome proliferator-activated receptors (PPARs) in mice, which may indicate its usefulness in fighting inflammation.
If you’re using CBD, it’s a good idea to do some research to inform your dosage . Young children can tolerate daily doses of up to 20 milligrams per kilogram of body weight . For a 175-pound (79.4-kilogram) adult, that’s more than 1,500 milligrams. The most common side effect of large doses of CBD is sleepiness.
The Hebrew University of Israel published a study in 2015 that documented the potency of single-molecule CBD extract versus the potency of whole-plant CBD-rich extract. It found that extract taken from whole plant CBD-rich cannabis seemed to be therapeutically superior to single-molecule extract.
According to research , when CBD is introduced to our endocannabinoid system, it prevents the body from absorbing a pain-regulating compound known as anandamide, an endogenous cannabinoid. Inhibiting the absorption of this compound shunts excess quantities into the bloodstream that in turn, may reduce pain. CBD may also target specific spinal receptors helping to suppress pain and inflammation. In both human and animal models, CBD seems to have a variety of anti-inflammatory properties.
Also, CBD derived from industrial hemp lacks the incredibly diverse profile of different cannabinoids and terpenes found in whole-plant marijuana. CBD derived from hemp seems to have a weaker entourage effect.
Figuring out how much you should take is challenging as well; the dosage that alleviates one patient's pain might do very little for someone else. "And until we can study it, it's the wild west," Dr. Danesh says.
There's no question that CBD is the buzzy wellness product of the moment. If you live in a state where it's currently legal, you might feel like CBD has gone from being sort of around to absolutely everywhere all at once. Coffee shops sell CBD lattes, spas offer CBD facials, beauty companies are rushing to release lotions with CBD or hemp oils in their formulas. And everyone from your anxious coworker to your arthritis-suffering dad wants to get their hands on some CBD gummies.
I’ve heard of edibles, tinctures, vape pens. What’s the best way to take CBD?
It's also crucial to buy third-party-tested CBD for quality assurance (more on this later). Because the FDA doesn't regulate CBD, it is possible to buy a product that is more or less potent than advertised, or even contains small amounts of THC.
"Right now, you just have pharmacies trying to make some sort of sense out of it and say, 'Yes, it works for this,'" he says, "but that's not the way medicine is practiced—it should be based on evidence, and there's not a lot of evidence to really support these claims."
Tempted to give your pup one of those CBD dog biscuits? "Generally we expect CBD products to be safe, and they could show some benefit for anxiety in pets," says John Faught, DVM, a veterinarian based in Austin, Texas.
Watzl, B., Scuderi, P., and Watson, R. R. Marijuana components stimulate human peripheral blood mononuclear cell secretion of interferon-gamma and suppress interleukin-1 alpha in vitro. Int J Immunopharmacol. 1991;13(8):1091-1097. View abstract.
Rajesh M, Mukhopadhyay P, Batkai S, et al. Cannabidiol attenuates cardiac dysfunction, oxidative stress, fibrosis, and inflammatory and cell death signaling pathways in diabetic cardiomyopathy. J Am Coll Cardiol 2010;56(25):2115-25. View abstract.
How does it work ?
Valvassori SS, Elias G, de Souza B, et al. Effects of cannabidiol on amphetamine-induced oxidative stress generation in an animal model of mania. J Psychopharmacol 2011;25(2):274-80. View abstract.
Bass J, Linz DR. A Case of Toxicity from Cannabidiol Gummy Ingestion. Cureus. 2020;12(4):e7688. View abstract.
Yadav V, Bever C Jr, Bowen J, et al. Summary of evidence-based guideline: complementary and alternative medicine in multiple sclerosis: report of the guideline development subcommittee of the American Academy of Neurology. Neurology. 2014;82(12):1083-92. View abstract.